TFBS Bioscience (ROCO:6939) ROCE % : -2.72% (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is TFBS Bioscience ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TFBS Bioscience's annualized ROCE % for the quarter that ended in Jun. 2024 was -2.72%.

TFBS Bioscience ROCE % Historical Data

The historical data trend for TFBS Bioscience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TFBS Bioscience ROCE % Chart

TFBS Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

0.26

2.08

3.69

0.41

TFBS Bioscience Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial			10.51	1.30	1.79	-0.91	-2.72

TFBS Bioscience ROCE % Calculation

TFBS Bioscience's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	5.376	/	( ( (1363.402 - 103.811)	+	(1448.042 - 84.879) )	/ 2 )
	=	5.376	/	( (1259.591	+	1363.163)	/ 2 )
	=	5.376	/	1311.377
	=	0.41 %

TFBS Bioscience's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-36.668	/	( ( (1448.042 - 84.879)	+	(1420.824 - 88.088) )	/ 2 )
	=	-36.668	/	( ( 1363.163	+	1332.736 )	/ 2 )
	=	-36.668	/	1347.9495
	=	-2.72 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

TFBS Bioscience (ROCO:6939) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

TFBS Bioscience ROCE % Related Terms

Thank you for viewing the detailed overview of TFBS Bioscience's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

TFBS Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TFBS Bioscience Inc (ROCO:6939) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN

Website

https://www.tfbsbio.com

TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.

TFBS Bioscience Headlines

No Headlines